Responsive image

Common name

Sucroferric Oxyhydroxide

IUPAC name

pentairon(3+) ion disodium (2R,3R,4S,5S,6R)-2-{[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol trihydrate hydroxide octaoxidandiide

SMILES

O.O.O.[OH-].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[Na+].[Na+].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O

Compound class

Iron Preparations; Blood and Blood Forming Organs; Antianemic Preparations; Drugs for Treatment of Hyperkalemia and Hyperphosphatemia; Drugs for Treatment of Hyperkalemia and Hypophosphatemia; Iron Trivalent, Oral Preparations;

Therapeutic area

Common name

Sucroferric Oxyhydroxide

IUPAC name

pentairon(3+) ion disodium (2R,3R,4S,5S,6R)-2-{[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol trihydrate hydroxide octaoxidandiide

SMILES

O.O.O.[OH-].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[Na+].[Na+].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O

INCHI

InChI=1S/C12H22O11.5Fe.2Na.4H2O.8O/c13-1-4-6(16)8(18)9(19)11(21-4)23-12(3-15)10(20)7(17)5(2-14)22-12;;;;;;;;;;;;;;;;;;;/h4-11,13-20H,1-3H2;;;;;;;;4*1H2;;;;;;;;/q;5*+3;2*+1;;;;;8*-2/p-1/t4-,5-,6-,7-,8+,9-,10+,11-,12+;;;;;;;;;;;;;;;;;;;/m1.................../s1

FORMULA

C12H29Fe5Na2O23

Responsive image

Common name

Sucroferric Oxyhydroxide

IUPAC name

pentairon(3+) ion disodium (2R,3R,4S,5S,6R)-2-{[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol trihydrate hydroxide octaoxidandiide

Molecular weight

342.296

clogP

-3.863

clogS

3.675

HBond Acceptor

11

HBond Donor

8

Total Polar
Surface Area

189.53

Number of Rings

2

Rotatable Bond

5

Drug ID Common name Structure CAS SMILE Frequency
FDBF00249 (3R,4R)-tetrahydrofuran-3,4-diol Responsive image O1CC(C(C1)O)O 0.0024
1 , 1